Anti-CD28 [TGN1412 (Theralizumab)], Human IgG1, Fc Silent(TM), kappa, Clone: [TGN1412 Theralizumab], Monoclonal

Produktübersicht

• Artikelname: Anti-CD28 [TGN1412 (Theralizumab)], Human IgG1, Fc Silent(TM), kappa, Clone: [TGN1412 Theralizumab], Monoclonal
• Artikelnummer: ABA-AB04902-10.3-BT
• Hersteller Artikelnummer: Ab04902-10.3-BT
• Alternativnummer: ABA-AB04902-10.3-BT
• Hersteller: Absolute Antibody
• Wirt: Human
• Kategorie: Antikörper
• Spezies Reaktivität: Human, Primate
• Alternative Synonym: T-cell-specific surface glycoprotein CD28, TP44, TGN1112, 5.11A1, CD28-SuperMAB, TAB08, 9D7

Produktbeschreibung

The original mouse antibody 5.11A1 was generated by immunizing BALB/c mice with recombinant human CD28-Fc fusion protein and boosted with B lymphoma cell line transfected with human CD28. Later on the CDRs of the original mouse antibody were cloned into human IgG1 framework regions to obtain the humanized antibody.

Produkteigenschaften

• Klonalität: Monoclonal
• Klon-Bezeichnung: [TGN1412 Theralizumab]
• Isotyp: IgG1
• UniProt: P10747
• Puffer: PBS only.
• Target-Kategorie: CD28